Lee Frank D.
SEC Form 4 insider trading activity
Lee Frank D. has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including BHC, PCRX, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: May 26, 2026.
On the most recent filing, Lee Frank D. is listed as Director at Bausch Health Companies Inc. Inside the rolling window, Lee Frank D. reported no open-market purchases and 1 open-market sale totaling $133K in BHC.
Companies traded
Other insiders at BHC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$133K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lee Frank D. made?
Lee Frank D. has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including BHC, PCRX since 2026.
Which companies does Lee Frank D. trade?
Lee Frank D. has filed SEC Form 4 disclosures for 2 companies, including BHC, PCRX.
When was Lee Frank D.'s most recent SEC Form 4 filing?
Lee Frank D.'s most recent SEC Form 4 filing on Tracefour is dated May 26, 2026.
What is Lee Frank D.'s total buy and sell value in the current window?
Inside the rolling retention window, Lee Frank D. bought $0 and sold $133K based on SEC Form 4 filings.
What was Lee Frank D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 24,456 BHC shares on 2026-05-19, worth $133K, per SEC Form 4 filings.